IBS-C Questionnaire Study

计划入组 300 人 · 首次发布于 2021 年 7 月 20 日

A Chinese Herbal Medicine for IBS-C

计划入组 78 人 · 首次发布于 2024 年 3 月 20 日

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

计划入组 210 人 · 首次发布于 2008 年 11 月 24 日

Tenapanor(Ibsrela)

C₅₀H₆₆Cl₄N₈O₁₀S₂

Tegaserod(Zelnorm)

C₁₆H₂₃N₅O · Rx

IBS-624

IBS-80, LLC

United States

C & C Oxygen Company

United States

TUMME IBS HEALTHCARE PTY LTD

Australia

IBS Clinical Trial Participation Shows Demographic and Socioeconomic Disparities

EnteroBiotix Reports Promising Phase 2a Results for Novel Microbiome Therapy in IBS-C

Biomerica's inFoods IBS Test Shows Significant Pain Reduction in Clinical Trial, Particularly Effective for IBS-C and IBS-M Patients